Իսրայել - եբրայերեն - Ministry of Health

glaxo smith kline (israel) ltd - mupirocin - משחה - mupirocin 2 %w/w - mupirocin - mupirocin - acute primary bacterial skin infections susceptible to the drug e.g. impetigo and folliculitis.

Իսրայել - եբրայերեն - Ministry of Health

glaxo smith kline (israel) ltd - aciclovir - קרם - aciclovir 5 %w/w - aciclovir - aciclovir - for local treatment of genital herpes simplex.

Իսրայել - եբրայերեն - Ministry of Health

glaxo smith kline (israel) ltd - aciclovir - טבליה - aciclovir 400 mg - aciclovir - aciclovir - for the treatment of herpes simplex virus infections of the skin and mucous membranes including intial and recurrent genital herpes. for the suppression (prevention of recurrences) of recurrent herpes simplex infections in immune-competent patients. for the prophylaxis of herpes simplex infections in immune-compromised patients. for the treatment of herpes zoster infections . for the treatment of chickenpox.

Իսրայել - եբրայերեն - Ministry of Health

glaxo smith kline (israel) ltd - aciclovir - טבליה - aciclovir 200 mg - aciclovir - aciclovir - for the treatment of herpes simplex virus infections of the skin and mucous membranes including initial and recurrent genital herpes. for the suppression (prevention of recurrences) of recurrent herpes simplex infections in immune-competent patients. for the prophylaxis of herpes simplex infections in immune-compromised patients. for the treatment of herpes zoster infections . for the treatment of chickenpox.

Իսրայել - եբրայերեն - Ministry of Health

glaxo smith kline (israel) ltd - aciclovir - טבליות ניתנות לפיזור - aciclovir 800 mg - aciclovir - aciclovir - for the treatment of herpes simplex virus infections of the skin and mucous membranes including initial and recurrent genital herpes. for the suppression (prevention of recurrences) of recurrent herpes simplex infections in immune-competent patients. for the prophylaxis of herpes simplex infections in immune-compromised patients. for the treatment of herpes zoster infections . for the treatment of chickenpox in the following groups: 1. non-pregnant patients over 13 years-of-age who are otherwise healthy. 2. children over 12 months of age with a chronic cutaneous or pulmonary condition, or receiving long-term salicylate therapy. 3. children receiving short or intermittent courses of aerosolized corticosteroids.

Իսրայել - եբրայերեն - Ministry of Health

glaxo smith kline (israel) ltd - clobetasone butyrate - משחה - clobetasone butyrate 0.05 %w/w - clobetasone - clobetasone - topical treatment for corticosteroid responsive dermatosis

Իսրայել - եբրայերեն - Ministry of Health

glaxo smith kline (israel) ltd - clobetasone butyrate - קרם - clobetasone butyrate 0.05 %w/w - clobetasone - clobetasone - topical treatment for corticosteroid responsive dermatosis

Իսրայել - եբրայերեն - Ministry of Health

glaxo smith kline (israel) ltd - betamethasone as valerate - תמיסה - betamethasone as valerate 0.1 %w/w - betamethasone - betamethasone - treatment of steroid responsive dermatoses of the scalp such as psoriasis and seborrheic dermatitis.

Իսրայել - եբրայերեն - Ministry of Health

glaxo smith kline (israel) ltd - betamethasone as valerate - קרם - betamethasone as valerate 0.1 %w/w - betamethasone - betamethasone - treatment of inflammatory dermatoses responsive to topical corticosteroids.

Իսրայել - եբրայերեն - Ministry of Health

glaxo smith kline (israel) ltd - betamethasone as valerate - משחה - betamethasone as valerate 0.1 %w/w - betamethasone - betamethasone - inflammatory dermatoses responsive to topical corticosteroids.